Company intelligence / Profile preview

Fynch Bio

Cupertino, California, United States

Ownership: Private
Development stage: Other

Overview

Fynch Bio is a private life science tools company commercializing the eVOLVER continuous-culture framework originally developed at Boston University. The company provides automated, modular hardware and software for scalable microbial and cell culture experiments, enabling applications in directed evolution, experimental evolution, synthetic biology, and functional genomics. Its offering appears to center on research instrumentation and associated software rather than a therapeutic pipeline. Publicly available information suggests the company is active and operating its website, documentation resources, and open-source code repositories. Fynch Bio appears to serve academic and industrial research users seeking programmable, high-throughput culture control.

Industry: Drug Discovery Services

Partnerships

Boston University

Beyond the preview

Go deeper on Fynch Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fynch Bio.

Explore the full profile